CAPECITABINE VIATRIS 150 mg

DRUG2 trials

Sponsors

Institut De Cancerologie De L Ouest, Associazione Italiana Per Lo Studio Del Pancreas

Conditions

Patients with newly diagnosed advanced peritoneal metastasis from colorectal cancerpancreatic ductal adenocarcinoma

Phase 2

Systemic antitumor treatment with or without pressurized intraperitoneal aerosol chemotherapy (PIPAC) for colon peritoneal metastases – a multicentre phase II randomized trial (PIPOX02)

RecruitingCTIS2024-514560-10-00

Institut De Cancerologie De L OuestPatients with newly diagnosed advanced peritoneal metastasis from colorectal cancer

Start: 2025-06-12Target: 114Updated: 2024-10-11

Phase 3

A randomized phase III trial of short-course versus long-course pre-operative chemotherapy with mFOLFIRINOX or PAXG regimen for stage I-III pancreatic ductal adenocarcinoma (PDAC)

Not yet recruitingCTIS2024-519031-42-00

Associazione Italiana Per Lo Studio Del Pancreaspancreatic ductal adenocarcinoma

Target: 261Updated: 2024-11-18

Related Papers

Preoperative mFOLFIRINOX versus PAXG for stage I-III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trial.

2025-11-20